rs72651634
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000088.4(COL1A1):c.2010delT(p.Gly671AlafsTer95) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. P670P) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000088.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- Caffey diseaseInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), G2P, ClinGen
- combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1Inheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Ambry Genetics, ClinGen
- Ehlers-Danlos syndromeInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Ehlers-Danlos syndrome, arthrochalasia typeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen
- osteogenesis imperfecta type 1Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- osteogenesis imperfecta type 2Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- osteogenesis imperfecta type 3Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- osteogenesis imperfecta type 4Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen
- Ehlers-Danlos syndrome, classic type, 1Inheritance: AD Classification: MODERATE Submitted by: ClinGen
- Ehlers-Danlos syndrome, classic typeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Ehlers-Danlos/osteogenesis imperfecta syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- high bone mass osteogenesis imperfectaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL1A1 | NM_000088.4 | c.2010delT | p.Gly671AlafsTer95 | frameshift_variant | Exon 30 of 51 | ENST00000225964.10 | NP_000079.2 | |
| COL1A1 | XM_011524341.2 | c.1812delT | p.Gly605AlafsTer95 | frameshift_variant | Exon 27 of 48 | XP_011522643.1 | ||
| COL1A1 | XM_005257058.5 | c.2010delT | p.Gly671AlafsTer95 | frameshift_variant | Exon 30 of 49 | XP_005257115.2 | ||
| COL1A1 | XM_005257059.5 | c.1092delT | p.Gly365AlafsTer95 | frameshift_variant | Exon 17 of 38 | XP_005257116.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL1A1 | ENST00000225964.10 | c.2010delT | p.Gly671AlafsTer95 | frameshift_variant | Exon 30 of 51 | 1 | NM_000088.4 | ENSP00000225964.6 | ||
| COL1A1 | ENST00000476387.1 | n.359delT | non_coding_transcript_exon_variant | Exon 6 of 9 | 2 | |||||
| COL1A1 | ENST00000504289.1 | n.442delT | non_coding_transcript_exon_variant | Exon 1 of 2 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 44
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2
- -
PM2_supporting, PS4_moderate, PVS1 -
COL1A1-related disorder Pathogenic:1
The COL1A1 c.2010delT variant is predicted to result in a frameshift and premature protein termination (p.Gly671Alafs*95). This variant has been reported to be causative for osteogenesis imperfecta (OI) (Table 1, Family Hu7, Reported as P492fsX587, Ward et al. 2001. PubMed ID: 11317364; Patient 3, Balasubramanian et al. 2016. PubMed ID: 26863094; Supplementary Table 2, Bertoli-Avella et al. 2020. PubMed ID: 32860008; Table 3, Patient ID 31, Higuchi et al. 2021. PubMed ID: 33939306). This variant was also reported, along with a COL5A1 variant, in a family with a compound phenotype of OI and Ehlers-Danlos syndrome (Lin et al. 2019. PubMed ID: 31239369). Of note, two family members had both variants and the compound phenotypes, while two other members only had the COL1A1 variant and only the OI phenotype. This variant has not been reported in a large population database, indicating this variant is rare. Frameshift variants in COL1A1 are expected to be pathogenic. This variant is interpreted as pathogenic. -
Osteogenesis imperfecta, perinatal lethal Pathogenic:1
- -
Osteogenesis imperfecta type I Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 497350). This premature translational stop signal has been observed in individuals with osteogenesis imperfecta type I (PMID: 11317364; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gly671Alafs*95) in the COL1A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL1A1 are known to be pathogenic (PMID: 7942841, 9295084, 9443882). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at